preeclampsia – Medxy AI

The Growing Challenge of Preeclampsia: Evaluating the USPSTF Screening Model

By MedXY 02/11/2026

This article examines a comprehensive study on the effectiveness of the USPSTF preeclampsia risk assessment guidelines and the implementation of aspirin prophylaxis in modern obstetric care.

Neurology news

Early Postpartum Blood Pressure Optimization Preserves Brain Volume After Hypertensive Pregnancy: Insights from the POP-HT Trial

By MedXY 01/06/2026

The POP-HT randomized clinical trial imaging substudy demonstrates that intensive postpartum blood pressure management after hypertensive pregnancy is associated with significantly larger white matter and subcortical brain volumes, suggesting a critical window for neuroprotective intervention.

Cardiology news

Beyond the Diastolic Threshold: Isolated Severe Systolic Hypertension as a Potent Predictor of Maternal Risk

By MedXY 12/25/2025

A large-scale analysis of over 115,000 patients demonstrates that isolated severe systolic hypertension (SBP ≥160 mmHg) during delivery admission is independently associated with a dramatic, dose-dependent increase in severe maternal morbidity, including pulmonary edema and renal failure.

Cardiology news OB/GYN & Women's Health

Genetic Liability to Hypertensive Disorders of Pregnancy Predicts Increased Long‑Term Cardiovascular Risk: Mendelian Randomization and Polygenic Risk Evidence

By MedXY 11/28/2025

Genetic predisposition to preeclampsia and gestational hypertension is associated with higher risk of later-life cardiovascular disease; polygenic risk amplifies this risk, while obstetric history improves risk stratification beyond PRSs alone.

Clinical Updates news OB/GYN & Women's Health

Optimizing Nifedipine GITS Dosing in Severe Preeclampsia: Daily 60 mg versus 30 mg BID – Evidence from a Randomized Controlled Trial

By MedXY 09/19/2025

This RCT compares nifedipine GITS 30 mg twice daily versus 60 mg once daily in severe preeclampsia, finding similar blood pressure control but fewer emergent treatments with twice-daily dosing, informing safer antihypertensive strategies in pregnancy.

Clinical Updates news OB/GYN & Women's Health Specialties

The Microcirculation in Pregnancy: Guardian of Health or Victim of Preeclampsia?

By MedXY 08/13/2025

This article explores how microcirculation functions as a key regulator in normal pregnancy but is compromised in preeclampsia, revealing early hemodynamic mechanisms behind gestational hypertension.

news OB/GYN & Women's Health Specialties

Evaluating the Effectiveness of USPSTF Preeclampsia Guidelines for Aspirin Prophylaxis

By MedXY 07/29/2025

A recent study questions the specificity of USPSTF guidelines for preeclampsia risk assessment, highlighting challenges in identifying patients truly at high risk and ensuring targeted aspirin prophylaxis.

news OB/GYN & Women's Health Specialties

DM199 Shows Promise as a Potential Treatment for Preeclampsia

By MedXY 07/29/2025

DM199 has demonstrated safety and efficacy in reducing blood pressure among preeclampsia patients during a Phase 2 trial, offering hope for improved maternal and fetal outcomes.